Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
about
The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary diseaseEndoscopic bronchial valve treatment: patient selection and special considerationsPathogenesis of hyperinflation in chronic obstructive pulmonary diseasePulmonary hypertension and right heart dysfunction in chronic lung disease.Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitationsInspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension.Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trialsTreatment of acute lung injury by targeting MG53-mediated cell membrane repair.Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease--a randomized, multicenter, double-blind, placebo-controlled study.Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.Dyspnea affective response: comparing COPD patients with healthy volunteers and laboratory model with activities of daily livingBronchoscopic lung volume reduction.The effects of high intensity exercise during pulmonary rehabilitation on ventilatory parameters in people with moderate to severe stable COPD: a systematic review.Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients.Reduced dynamic hyperinflation after LVRS is associated with improved exercise tolerance.The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary DiseaseBench and mathematical modeling of the effects of breathing a helium/oxygen mixture on expiratory time constants in the presence of heterogeneous airway obstructionsSpirometric correlates of dyspnea improvement among emergency department patients with chronic obstructive pulmonary disease exacerbationThe Impact of Homogeneous Versus Heterogeneous Emphysema on Dynamic Hyperinflation in Patients With Severe COPD Assessed for Lung Volume Reduction.Update in chronic obstructive pulmonary disease 2006.A human model of the pathophysiology of chronic obstructive pulmonary disease.Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation.COPD: what is the unmet need?Preliminary study on the assessment of visceral adipose tissue using dual-energy x-ray absorptiometry in chronic obstructive pulmonary disease.Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis.Influence of heart failure on resting lung volumes in patients with COPDEffects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study.Is 'GOLD' standard for the management of COPD in clinical practice?Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis.Descriptors of dyspnea in obstructive lung diseases.No room to breathe: the importance of lung hyperinflation in COPD.Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment.Examining the role of activity, exercise, and pharmacology in mild COPD.Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold?Extrinsic Threshold PEEP Reduces Post-exercise Dyspnea in COPD Patients: A Placebo-controlled, Double-blind Cross-over StudyEffect of Yoga Breathing (Pranayama) on Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Trial.How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?Pathophysiology of dyspnea in COPD.Pulmonary rehabilitation: the reference therapy for undernourished patients with chronic obstructive pulmonary disease
P2860
Q22305858-1C0CB822-8665-4126-AF44-0C697CD6F830Q26778692-58710AB0-A184-4638-924A-F6781C51039DQ27011554-7BEDF263-44B2-460F-8BC3-0A3746539306Q30432299-2353167F-6F8E-45B8-BAA2-885DDC850901Q30480535-B748FC63-5B6A-45D2-B711-86DAE7C04AE4Q33788576-AE9A1A03-87E1-41E6-B289-17B13FE067E8Q33824534-A64F5DAE-74C5-445E-99D0-350326CF6950Q33942287-0745C74E-78E1-4117-97CA-0D4F00BA8E6CQ34340387-73348BAC-1DB8-4294-A5C1-EE74509A8F11Q34560231-D43BFC4A-6239-43F0-B488-A9D4B5499ABFQ34690614-0B5EF7C1-26C4-4D7C-8B05-9B247F7E4E2CQ35047097-0A18B6BE-162B-489A-845A-4E0BBB629880Q35346424-95E2A993-D7E9-4DCF-928B-8C7093C9C166Q35576594-934CBEAB-5368-4A39-B7D0-3F1215DAF02EQ35861925-3CAE5329-DE02-453A-A4C9-B8E6C9297A28Q36075457-F4E5FB7B-A7CC-4A03-BA33-E831F6A70CFCQ36398193-9CF89F42-84A8-4D26-BEB6-C2EDE3F6975DQ36469780-B1977932-D938-42EA-B872-796DE1D13242Q36647156-4392DAAC-3975-4B82-B5F1-9F6DFFFAD3C3Q36838782-A1A34DC5-61DC-4CED-A86C-A13D7A21D755Q36857554-1F10A7A2-E64C-49FA-957B-07BAFF5C6953Q36923017-781A8270-4AB5-4B8A-A0DE-BC489164A6DCQ36964961-9658C4DC-F397-4E23-A75E-C532D09D6FB8Q37307991-4FEB895E-E783-4AE6-BCFA-3BA072B8EA7CQ37316767-51940458-AEA8-4FE9-8CFF-11128F80600AQ37337865-AAA29CA1-E7F9-4809-9CE4-1FD1D9BB70E7Q37392356-08FADCEF-207D-4C84-9CF5-F6F104084FD8Q37450159-C43C1A88-4554-4190-A72B-2F76F3BC4862Q37578975-ECEE2C20-209F-4F83-BDFF-52F03D5D1869Q37701943-E3AF873F-5235-4658-9B21-BB6AFD073D6BQ38041664-BD22AB56-4870-44A9-9986-CA438D9B3AE3Q38083537-6655E3BB-C129-48A5-B808-3EBEC8366E83Q38243468-E49C65E9-FAA7-4934-80AF-A525A1BB69D2Q38258106-46F63B84-8A5F-4737-868F-B5B859A52A3FQ38258537-7ECD4B6C-0E75-403E-A683-9799353FE56EQ38268855-BB4771C3-659F-4D4C-B399-CF44762FD832Q38656563-2E9C6842-2306-41AA-A804-FF2602283785Q39030602-88551455-A56B-4A47-8387-BA7CBF178C00Q39170919-B7E3A45A-5541-448F-91DA-12709EA04717Q39216001-EF2EEB78-6394-412D-9EED-B1A6B739709D
P2860
Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@ast
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@en
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@en-gb
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@nl
type
label
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@ast
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@en
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@en-gb
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@nl
altLabel
Hyperinflation, dyspnea, and e ...... obstructive pulmonary disease
@en
prefLabel
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@ast
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@en
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@en-gb
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@nl
P3181
P1476
Hyperinflation, Dyspnea, and E ...... Obstructive Pulmonary Disease
@en
P2093
D. E. O'Donnell
P304
P3181
P356
10.1513/PATS.200508-093DO
P407
P577
2006-04-01T00:00:00Z